Conversely, no cardiac compromise was observed, as previously described in several patients with IGH::IL3‐rearranged BCP‐ALL, and the extent of organ damage was mild compared to previous reports [2, 3, 10]. This evidence concerns the gene IL3 and acute lymphoblastic leukemia.